Invivyd, Inc. (IVVD) vs Sutro Biopharma, Inc. (STRO)
Invivyd, Inc. and Sutro Biopharma, Inc. are both Biotechnology companies. Invivyd, Inc. and Sutro Biopharma, Inc. are of similar size ($274.1M and $260.5M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against −56.3%. Invivyd, Inc. has the higher net margin (−183.9% vs −395.3%) and the lower return on invested capital (−334.9% vs 0.00%). Across the 15 metrics below, Invivyd, Inc. leads on 11 and Sutro Biopharma, Inc. on 4.
Valuation
Profitability
| Metric | IVVD | STRO | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 100.00% | 65.16% |
| Operating margin | (192.81%) | (319.57%) | 0.00% |
| Net margin | (183.90%) | (395.25%) | 0.00% |
| Free cash flow margin | (187.88%) | (318.63%) | 0.00% |
| Return on equity | (95.89%) | 266.76% | (57.72%) |
| Return on assets | (69.69%) | (79.08%) | (49.22%) |
| Return on invested capital | (334.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack